A study has revealed that a protein of roundworm larvae which needs to invade the intestines of rodents to survive could be used to control inflammation.
List view / Grid view
Helmholtz Zentrum München
Filter the results
A label-free imaging technology has been developed by researchers, allowing them to investigate biomolecules such as metabolites, aiding in the study of drugs.
A research team has shown that a key difference between neurogenic and non-neurogenic tissues is cross-linking proteins causing stiffness, a discovery that could be used to create new brain injury therapies.
Researchers have developed algorithms that make it possible to predict and correct cells to identify genes...
Scientists have armed immune cells with a new surface molecule that causes them to respond aggressively when they encounter a protein that tumours actually use to camouflage themselves from the immune system. Researchers from the Helmholtz Zentrum München and various partners introduced the method in ‘Cancer Research’.
Autonomous driving, automatic speech recognition, and the game Go: Deep Learning is generating more and more public awareness.
In this Screening In-Depth Focus, scientists from the Assay Development and Screening Platform of Helmholtz Zentrum München provide an overview of different high-throughput screening (HTS)-applicable assay types that can be applied to drug discovery campaigns. Plus an interview with Lee Babiss, CEO of drug discovery firm X-Rx, on the benefits…
17 October 2016 | By Niamh Louise Marriott, Digital Content Producer
An efficient and safe medicine, which would reverse obesity, insulin resistance, fatty liver and atherosclerosis remains a major scientific challenge...
5 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The virus drives production of small molecules, so-called microRNAs, which suppress alarm signals sent out by the infected cell...
15 June 2015 | By Victoria White
Scientists at Helmholtz Zentrum München have discovered that Epstein-Barr virus (EBV) conceals itself in human cells using the LMP2A protein.
12 June 2015 | By Victoria White
Scientists have created 3D organoid-structures that recapitulate normal breast development and function from single patient-derived cells...
29 October 2013 | By Kenji Schorpp, Assay Development and Screening Scientist, Helmholtz Center.
Kenji Schorpp, Assay Development and Screening Scientist, talks to Drug Target Review about his work at the Helmholtz Center...